Concepedia

Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine

Claudio Ponticelli, A Yussim, V. Cambi, C. Legendre, Giuseppe Rizzo, Maurizio Salvadori, D. Kahn, S. Habib Kashi, K. Salmela, Lutz Fricke,

Transplantation Proceedings · 2001 · 16 citations · 4 references

DOI

Concepts

References

4

International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology

Kim Solez, Roy A. Axelsen, Hallgrímur Benediktsson et al. · Kidney International · 1993 · 1.5K citations

, , +17

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

Björn Nashan, Richard H. Moore, P L Amlot et al. · The Lancet · 1997 · 762 citations

, , +15

REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2

Barry D. Kahan, P. R. Rajagopalan, Michael Hall · Transplantation · 1999 · 483 citations

, , +17

PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATION

P L Amlot, E Rawlings, Ossie N. Fernando et al. · Transplantation · 1995 · 184 citations

, , +11